BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10368494)

  • 1. Serum and tissue hormone levels of vaginally and orally administered estradiol.
    Tourgeman DE; Gentzchein E; Stanczyk FZ; Paulson RJ
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1480-3. PubMed ID: 10368494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and clinical effects of micronized estradiol administered vaginally or orally.
    Tourgeman DE; Slater CC; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2001 Jan; 75(1):200-2. PubMed ID: 11163838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study.
    Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A
    Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.
    Nahoul K; Dehennin L; Jondet M; Roger M
    Maturitas; 1993 May; 16(3):185-202. PubMed ID: 8515718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.
    Miles RA; Paulson RJ; Lobo RA; Press MF; Dahmoush L; Sauer MV
    Fertil Steril; 1994 Sep; 62(3):485-90. PubMed ID: 8062942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High local endometrial effect of vaginal progesterone gel.
    Ficicioglu C; Gurbuz B; Tasdemir S; Yalti S; Canova H
    Gynecol Endocrinol; 2004 May; 18(5):240-3. PubMed ID: 15346659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and endometrial effects of the vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women.
    Cicinelli E; Borraccino V; Petruzzi D; Mazzotta N; Cerundolo ML; Schönauer LM
    Fertil Steril; 1996 Apr; 65(4):860-2. PubMed ID: 8654651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
    Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
    Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route.
    Devoto L; Fuentes A; Palomino A; Espinoza A; Kohen P; Ranta S; von Hertzen H
    Fertil Steril; 2005 Jul; 84(1):46-51. PubMed ID: 16009156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone administration in patients with absent ovaries.
    Devroey P; Palermo G; Bourgain C; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Int J Fertil; 1989; 34(3):188-93. PubMed ID: 2567713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer.
    Liao X; Li Z; Dong X; Zhang H
    Int J Clin Exp Pathol; 2014; 7(10):6992-7. PubMed ID: 25400786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol and progesterone replacement regimens for the induction of endometrial receptivity.
    Steingold K; Stumpf P; Kreiner D; Liu HC; Navot D; Rosenwaks Z
    Fertil Steril; 1989 Nov; 52(5):756-60. PubMed ID: 2806616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal versus oral E(2) administration: effects on endometrial thickness, uterine perfusion, and contractility.
    Fanchin R; Righini C; Schönauer LM; Olivennes F; Cunha Filho JS; Frydman R
    Fertil Steril; 2001 Nov; 76(5):994-8. PubMed ID: 11704123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women.
    Pasquale SA; Foldesy RG; Levine JP; Bachmann GA; Blackwell RE
    Fertil Steril; 1997 Nov; 68(5):810-5. PubMed ID: 9389807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial responses to various hormone replacement regimens in ovarian failure patients preparing for embryo donation.
    Sauer MV; Stein AL; Paulson RJ; Moyer DL
    Int J Gynaecol Obstet; 1991 May; 35(1):61-8. PubMed ID: 1680078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.